Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Receives $8.1 M In First Financing Round

Premium

B

EVERLY, Mass.--Proteome, an internet provider of biological knowledge databases to pharmaceutical and biotechnology researchers, has just announced that it received $8.1 million in venture capital financing in December last year from Boston Millennia Partners and William Blair Capital Partners. The company, founded in 1995, uses curators to prepare databases of gene and protein information by annotation of the scientific literature.

More than 25 pharmaceutical and biotechnology companies subscribe to Proteome databases, collectively called the BioKnowledge Library. Academic laboratories are allowed free, limited use of the company’s model organism databases via the internet. Expanding on its yeast and worm gene and protein databases, the company plans to include databases that link to the human genome.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.